APA (7th ed.) Citation

D, L., T, L., L, G., X, L., C, L., P, A., . . . JY, J. (2020). Integrated Two-Analyte Population Pharmacokinetic Model of Polatuzumab Vedotin in Patients With Non-Hodgkin Lymphoma. CPT: pharmacometrics & systems pharmacology, 9(1), 48. https://doi.org/10.1002/psp4.12482

Chicago Style (17th ed.) Citation

D, Lu, et al. "Integrated Two-Analyte Population Pharmacokinetic Model of Polatuzumab Vedotin in Patients With Non-Hodgkin Lymphoma." CPT: Pharmacometrics & Systems Pharmacology 9, no. 1 (2020): 48. https://doi.org/10.1002/psp4.12482.

MLA (9th ed.) Citation

D, Lu, et al. "Integrated Two-Analyte Population Pharmacokinetic Model of Polatuzumab Vedotin in Patients With Non-Hodgkin Lymphoma." CPT: Pharmacometrics & Systems Pharmacology, vol. 9, no. 1, 2020, p. 48, https://doi.org/10.1002/psp4.12482.